- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01319552
Fresh Versus Old Red Blood Cells for Transfusion
May 15, 2015 updated by: Steven L. Spitalnik, Columbia University
Immunomodulatory Properties of Fresh Versus Stored Packed Red Blood Cells for Transfusion
Packed red blood cell units destined for transfusion can be stored for up to 42 days prior to transfusion based on Food and Drug Administration (FDA) guidelines.
Recent studies suggest that certain patients transfused with blood stored for longer duration have poorer outcomes than patients transfused fresher blood.
The investigators' hypothesis is that the delivery of an immediate and substantial load of hemoglobin-associated iron from a stored unit of blood leads to changes that explain the differences in outcome between patients transfused old versus fresh blood.
The investigators propose to test this hypothesis in humans by transfusing an individual's own blood, both fresh and after storage, and comparing levels of various outcome measures.
Study Overview
Status
Completed
Intervention / Treatment
Detailed Description
Participants in this study will be asked to participate in a standard blood donation.
The blood will be processed per standards at the investigators regional blood center (New York Blood Center) and then split into two equal units and shipped to Columbia University Medical Center for storage and transfusion.
One unit will be transfused back into the same individual fresh (i.e. between 3-7 days after donation).
The other unit will be transfused 42 days after donation.
Blood samples will be drawn before, during, and after transfusion to measure levels of various analytes.
Study Type
Interventional
Enrollment (Actual)
14
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
New York
-
New York, New York, United States, 10032
- Columbia University Medical Center
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 65 years (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- healthy
- male body weight >130 lbs, female body weight > 155 lbs
- male height >5'1", female height >5'5"
- hemoglobin >13.3 g/dL
Exclusion Criteria:
- ineligible for donation based on the New York Blood Center autologous blood donor questionnaire
- systolic blood pressure >180 or <90 mm Hg
- diastolic blood pressure >100 or <50 mm Hg
- heart rate <50 or >100
- temperature >99.5 F prior to donation
- temperature >100.4 F or subjective feeling of illness prior to transfusion
- positive results on standard blood donor infectious disease testing
- pregnancy.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Non-Randomized
- Interventional Model: Crossover Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Other: Fresh transfusion
1 unit autologous transfusion of red blood cells stored for 3-7 days under standard conditions
|
1 unit autologous transfusion of red blood cells stored for 3-7 days under standard conditions
Other Names:
1 unit autologous transfusion of red blood cells stored for 40-42 days under standard conditions
Other Names:
|
|
Experimental: Old transfusion
1 unit autologous transfusion of red blood cells stored for 40-42 days under standard conditions
|
1 unit autologous transfusion of red blood cells stored for 3-7 days under standard conditions
Other Names:
1 unit autologous transfusion of red blood cells stored for 40-42 days under standard conditions
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Measure of Non-transferrin-bound Iron
Time Frame: four hours after transfusion
|
Comparison of increase in non-transferrin-bound iron for each participant between his or her "fresh" and "old" blood transfusion four hours after transfusion.
|
four hours after transfusion
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Collaborators
Investigators
- Principal Investigator: Spitalnik L Spitalnik, MD, Columbia University
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
December 1, 2008
Primary Completion (Actual)
October 1, 2010
Study Completion (Actual)
October 1, 2010
Study Registration Dates
First Submitted
March 18, 2011
First Submitted That Met QC Criteria
March 18, 2011
First Posted (Estimate)
March 21, 2011
Study Record Updates
Last Update Posted (Estimate)
June 2, 2015
Last Update Submitted That Met QC Criteria
May 15, 2015
Last Verified
May 1, 2015
More Information
Terms related to this study
Keywords
Other Study ID Numbers
- AAAD3737
- R01HL098014 (U.S. NIH Grant/Contract)
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Iron, Abnormal Blood Level
-
Columbia UniversityNational Heart, Lung, and Blood Institute (NHLBI)CompletedIron, Abnormal Blood LevelUnited States
-
Columbia UniversityNational Heart, Lung, and Blood Institute (NHLBI)Completed
-
Fondazione Policlinico Universitario Agostino Gemelli...CompletedIron-deficiency | Anemia | Iron Deficiency Anemia | Iron Deficiency Anemia Treatment | Blood Loss Anemia | Erythropoiesis AbnormalItaly
-
Hamad Medical CorporationCompletedBronchiolitis | Magnesium, Abnormal Blood LevelQatar
-
University of CalgaryNot yet recruitingIron Deficiency Anemia | Abnormal Uterine Bleeding
-
Baylor College of MedicineCompletedIron Deficiency Anemia | Heavy Menstrual Bleeding | Abnormal Uterine BleedingUnited States
-
University of British ColumbiaCompleted
-
University of British ColumbiaCompletedHeart Rate | Blood Oxygen Saturation LevelCanada
-
Swiss Federal Institute of TechnologyJomo Kenyatta University of Agriculture and TechnologyCompletedIron-deficiency | Iron Absorption | Ferritin Threshold | Stable Iron IsotopesKenya
-
Pierre Fabre Pharma AGCompletedIron-Deficiency Anemia | Iron-DeficiencySwitzerland
Clinical Trials on Fresh transfusion
-
Rutgers, The State University of New JerseyJohns Hopkins University; National Heart, Lung, and Blood Institute (NHLBI); University... and other collaboratorsCompletedHemorrhage | Blood Coagulation DisordersUnited States
-
Mayo ClinicCompletedSurgical Procedures, Minimally Invasive | Blood Coagulation, DisordersUnited States
-
Emory UniversityTerminated
-
University of Colorado, DenverCompletedLiver DiseaseUnited States
-
National Institutes of Health Clinical Center (CC)Terminated
-
Assistance Publique - Hôpitaux de ParisCompletedMyocardial Infarction | Anemia | Blood TransfusionSpain, France
-
Assistance Publique - Hôpitaux de ParisInstitut National de la Santé Et de la Recherche Médicale, France; Etablissement... and other collaboratorsCompletedThe Focus is on the Detection of the Consequences of Autologous Blood Transfusion in Healthy VolunteersFrance
-
NICHD Neonatal Research NetworkNational Heart, Lung, and Blood Institute (NHLBI)RecruitingInfant, Newborn, Diseases | Thrombosis | Thrombocytopenia | Infant, Extremely Low Birth Weight | Infant, Small for Gestational Age | Neonatal | Platelet TransfusionUnited States
-
Bristol-Myers SquibbCompletedLower-risk Myelodysplastic SyndromesJapan